Helsinn Announces the Launch of Adlumiz® (anamorelin) for the Treatment of Cancer Cachexia in Japan

Frank Burrell
Scientific Storytelling

Bud Bilanich
Success Coach

Brenda Snow
Authentic Patient Voice

Daniel Sontupe
Market Access

Matt Turner
Patient Affordability

Liz Kane
Impactful Strategy

David Linetsky
Patient Activation

Mike Viscel
Increasing Engagement

Frank X. Powers
Healthcare Challenger Brands

Pat Purcell
Meeting Engagement

Thomas Shea
Programmatic Marketing

Matthew Durham
Omnidynamic Marketing

Amy Giles
Increasing Engagement

Laura Blair
Medication Adherence

Anil Bhaskar
Unified Customer Experience

Paul Theisen
Patient Acquisition

Stacey Gandler
Brand Nourishment

Suma Ramadas, PhD
Medical Affairs